GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B3 Mar 28, 2024 424B3
424B3 Mar 28, 2024 424B3
10-K Mar 28, 2024 10-K
SC 13G/A Feb 13, 2024 AMENDMENT TO FORM SC 13G
424B3 Feb 2, 2024 424B3
8-K Feb 2, 2024 8-K
424B4 Feb 2, 2024 424B4
EFFECT Feb 1, 2024
S-1/A Jan 31, 2024 S-1/A
S-1/A Jan 31, 2024 S-1/A
CORRESP Jan 30, 2024
CORRESP Jan 30, 2024
424B3 Jan 30, 2024 424B3
8-K Jan 30, 2024 8-K
424B3 Jan 19, 2024 424B3
8-K Jan 19, 2024 8-K
8-K Jan 16, 2024 8-K
424B3 Jan 8, 2024 424B3
DEFA14A Jan 8, 2024 DEFA14A
8-K Jan 8, 2024 8-K
DEF 14A Jan 2, 2024 DEF 14A
UPLOAD Dec 26, 2023
S-1 Dec 21, 2023 S-1
PRE 14A Dec 20, 2023 PRE 14A
EFFECT Dec 15, 2023
← Newer Page 8 of 17 · 401 filings Older →